Ethyl 2-(4-methylpent-2-enoyl)thiazole-4-carboxylate, 97.0%, 1g

2-(1-Methyl-1H-pyrazol-4-yl)morpholine, 98%, 250mg

N-(4-ethylphenyl)-4-methylbenzenesulfonamide, 95%, 250mg

Methyl 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoate, 97.0%, 250mg

4,6-Dichloro-2-(4-chlorophenyl)pyrimidine, 1g

2-Aminopent-4-ynoic acid, 95.0%, 5g

(1R*,4R*)-4-(2-Aminophenylamino)cyclohexanol, 1g

3-(Benzyloxy)-2-methyl-4H-pyran-4-one, 97.0%, 250mg

6-Bromo-2-naphthaldehyde>98.0%(GC)1g

5-Amino-1H-1,2,4-triazol-3(2H)-one, 95.0%, 250mg

Quartz, min. 99% powder, up to 125 µm, 5 kg, plastic packaging.

ETHYL 3-(2,6-DICHLORO-5-FLUOROPYRIDIN-3-YL)-3-OXOPROPANOATE, 95.0%, 100g

Tert-butyl (S)-4-hydroxyazepane-1-carboxylate, 95+%, 1g